The University of Rochester Medical Center is pleased to announce the addition of Eva Galka, M.D. as an Assistant Professor of Surgery. Dr. Galka earned two Bachelor of Science degrees, with high honors, in Ceramic Engineering and Biomedical Engineering & Applied Sciences from Rutgers University College of Engineering in New Brunswick, New Jersey. She received her medical degree from Dartmouth Medical School in Hanover, New Hampshire.
From 2000 through 2007, Dr. Galka completed her internship and residency in general surgery, as well as a two-year fellowship in surgical research, at Pennsylvania State University/Hershey Medical Center in Pennsylvania. Prior to joining URMC, Dr. Galka was a surgical oncology fellow at the University of Chicago in Illinois. She is licensed to practice medicine in the states of New York and Illinois and is board certified by the American Board of Surgery.
Dr. Galka has been the recipient of numerous awards and grants including the John Waldhausen Fellowship Award for Research, the American Physiological Society Research Recognition Award for Outstanding Abstract Presentation, the American Society of Colon and Rectal Surgeons (ASCRS) Research Grant and the University of Chicago Breast Cancer SPORE Developmental Research Project Grant. She has authored a wide variety of publications and has given numerous presentations at national surgery meetings throughout the United States.
In addition to being a member of professional organizations including the Society of Surgical Oncology, American Society of Clinical Oncology, American College of Surgeons, Association of Academic Surgeons and American Association of Cancer Research, Dr. Galka has developed clinical trials such as "A Pilot Study of Chemoprevention of Green Tea (Polyphenon E) in Women with Ductal Carcinoma in Situ (DCIS)."
Dr. Galka's clinical interests include the management of gastrointestinal malignancie (particularly pancreatic and hepatobiliary cancers), melanoma and sarcoma. Her research interests include understanding the mechanisms of apoptosis (programmed cell death) and its relation to novel treatments for cancer.

• Sepesi B, Moalem J, Galka E, Salzman P, Schoeniger LO. The influence of staple size on fistula formation following distal pancreatectomy. J Gastrointest Surg. 2012 Feb; 16(2):267-74.
  View in: PubMed
• Bickenbach K, Galka E, Roggin KK. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma? Surg Oncol Clin N Am. 2009 Apr; 18(2):215-24, vii.
  View in: PubMed
• Mauceri HJ, Beckett MA, Liang H, Sutton HG, Pitroda S, Galka E, Efimova E, Darga T, Khodarev NN, King CR, Posner MC, Hellman S, Kufe DW, Weichselbaum RR. Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy. Cancer Gene Ther. 2009 Apr; 16(4):373-81.
  View in: PubMed
• Rogers AM, Capen J, Galka E, Cooney RN. Tubulovillous adenoma with atypia found at gastrojejunal anastomosis 8 years after gastric bypass for morbid obesity. Surg Obes Relat Dis. 2007 Sep-Oct; 3(5):559-60.
  View in: PubMed
• Galka E, Thompson JL, Zhang WJ, Poritz LS, Koltun WA. Stat6(null phenotype) human lymphocytes exhibit increased apoptosis. J Surg Res. 2004 Nov; 122(1):14-20.
  View in: PubMed
• Zhang WJ, Koltun WA, Thompson JL, Tilberg AF, Galka E, Poritz LS, Chorney MJ. Human B lymphoblast cell lines defective of Stat6 signaling produce high levels of proinflammatory cytokines IL-12, TNFalpha and IFNgamma. Int J Oncol. 2004 Feb; 24(2):447-53.
  View in: PubMed
• Galka E, Goldfarb HA. Disseminated intravascular coagulation as a complication of intrauterine balloon tamponade for posthysteroscopic acute uterine bleeding. J Am Assoc Gynecol Laparosc. 2000 Nov; 7(4):573-6.
  View in: PubMed
• Blaszczyk M, Galka E, Sakowicz E, Mycielski R. Denitrification of high concentrations of nitrites and nitrates in synthetic medium with different sources of organic carbon. III. Methanol. Acta Microbiol Pol. 1985; 34(2):195-205.
  View in: PubMed